These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19110196)

  • 1. Multifunctional drug treatment in neurotrauma.
    Stoica B; Byrnes K; Faden AI
    Neurotherapeutics; 2009 Jan; 6(1):14-27. PubMed ID: 19110196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of riluzole in neurotrauma models: a review.
    Wahl F; Stutzmann JM
    Acta Neurochir Suppl; 1999; 73():103-10. PubMed ID: 10494351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel small peptides with neuroprotective and nootropic properties.
    Faden AI; Knoblach SM; Movsesyan VA; Cernak I
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S93-7. PubMed ID: 15665420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate antagonists and thyrotropin-releasing hormone. II. Potential role in the treatment of central nervous system injury.
    Faden AI
    JAMA; 1984 Sep; 252(11):1452-4. PubMed ID: 6433052
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of melatonin in traumatic brain injury and spinal cord injury.
    Naseem M; Parvez S
    ScientificWorldJournal; 2014; 2014():586270. PubMed ID: 25587567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional drugs for head injury.
    Vink R; Nimmo AJ
    Neurotherapeutics; 2009 Jan; 6(1):28-42. PubMed ID: 19110197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection and secondary damage following spinal cord injury: concepts and methods.
    Hilton BJ; Moulson AJ; Tetzlaff W
    Neurosci Lett; 2017 Jun; 652():3-10. PubMed ID: 27939975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole.
    Schwartz G; Fehlings MG
    Prog Brain Res; 2002; 137():177-90. PubMed ID: 12440368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function and Mechanisms of Autophagy in Brain and Spinal Cord Trauma.
    Lipinski MM; Wu J; Faden AI; Sarkar C
    Antioxid Redox Signal; 2015 Aug; 23(6):565-77. PubMed ID: 25808205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate-receptor antagonists, thyrotropin-releasing hormone (TRH), and TRH analogs in the treatment of spinal cord injury.
    Faden AI
    Cent Nerv Syst Trauma; 1987; 4(4):217-26. PubMed ID: 3128405
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationships of TRH analogs in rat spinal cord injury.
    Faden AI; Sacksen I; Noble LJ
    Brain Res; 1988 May; 448(2):287-93. PubMed ID: 3132308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection for traumatic brain injury.
    Loane DJ; Stoica BA; Faden AI
    Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
    Faden AI
    Cent Nerv Syst Trauma; 1985; 2(1):5-8. PubMed ID: 3004747
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone: basis and potential for its therapeutic use.
    Kelly JA
    Essays Biochem; 1995; 30():133-49. PubMed ID: 8822153
    [No Abstract]   [Full Text] [Related]  

  • 16. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration.
    De Nicola AF; Labombarda F; Gonzalez Deniselle MC; Gonzalez SL; Garay L; Meyer M; Gargiulo G; Guennoun R; Schumacher M
    Front Neuroendocrinol; 2009 Jul; 30(2):173-87. PubMed ID: 19318112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions.
    Feeser VR; Loria RM
    J Neuroimmunol; 2011 Aug; 237(1-2):4-12. PubMed ID: 21777982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro model of neurotrauma in organotypic spinal cord cultures from adult mice.
    Krassioukov AV; Ackery A; Schwartz G; Adamchik Y; Liu Y; Fehlings MG
    Brain Res Brain Res Protoc; 2002 Oct; 10(2):60-8. PubMed ID: 12431704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of novel small peptides in vitro and after brain injury.
    Faden AI; Movsesyan VA; Knoblach SM; Ahmed F; Cernak I
    Neuropharmacology; 2005 Sep; 49(3):410-24. PubMed ID: 15907950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and cognitive enhancing effects of novel small peptides.
    Faden AI; Fox G; Fan L; Knoblach S; Araldi GL; Kozikowski AP
    Ann N Y Acad Sci; 1999; 890():120. PubMed ID: 10668419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.